Survey and Reduction of Mortality in Uremic Patients During Peridialysis Period Via Intervention of Risk Factors
试验速览
- 阶段
- 不适用
- 入组人数
- 2,500
- 试验地点
- 1
- 主要终点
- mortality
研究概览
简要总结
In patients with non-dialysis-dependent end stage kidney disease (ESKD) the common transition of care to renal replacement therapy is dialysis. Each year over 70 000 Chinese transition from non-dialysis-dependent ESKD to dialysis. Whereas dialysis therapy is intended to be life-sustaining, ESKD patients have a 10-fold or higher risk of death compared with the general population. Mortality rates are even higher upon transition and in the first year, especially in the first 3 to 6 months following the transition to dialysis, yet it remains unknown which is the contributing cause of this high death rate. Hence, there is an urgent need to examine the emerging field of Transition of Care in ESKD. We suggest the term "peridialysis period" for this transition period for ESKD patients, so that the transition of care from non-dialysis-dependent ESKD to dialysis ESKD can be more pragmatically defined and studied. In the current study, we will investigate the mortality and its risk factors of ESKD patients during peridialysis period, and improve the survival rate and quality of life of peridialysis ESKD patients by intervening the risk factors.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Screening
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients who have been diagnosed with end stage kidney disease (eGFR<15ml/min/1.73m2) or newly started dialysis with 3 months at all hospitals in Yangzhou, China since January 1, 2016
排除标准
- •Patients who have had a history of dialysis and have been transferred to Yangzhou during this period;
- •patients who are transferred to a dialysis area outside Yangzhou City
- •Patients who give up dialysis treatment
- •patient whose renal function recover and stop dialysis treatment;
- •Patient who receive kidney transplantation
研究组 & 干预措施
intervention group
Through the effective intervention of risk factors for death in patients with dialysis, the effect of mortality of peri-dialysis patients was observed.
干预措施: intervention group (Combination Product)
结局指标
主要结局
mortality
时间窗: one year
mortality and death cause
次要结局
- hospitalization(one year)
研究者
Changlin Mei
Director of Kidney Institution of PLA
Shanghai Changzheng Hospital
